Ketamine vs SSRIs for Depression

If you've tried one SSRI, waited 4-6 weeks for it to work, felt no better, and then repeated that cycle with a second or third medication, you understand the exhaustion of waiting for relief that never arrives. You're not alone: roughly one-third of people with depression don't respond adequately to their first two medication trials. Each unsuccessful trial represents not just disappointment but months of your life spent hoping the next adjustment will finally work.

If you're here because you want to know if there's something faster, something that works differently, you're in the right place.

The short answer: Ketamine works significantly faster than SSRIs, often within hours rather than weeks. For treatment-resistant depression, ketamine offers a 50-70% response rate. The tradeoffs: ketamine's effects typically last several days to about a week per treatment (requiring maintenance), and cost remains a barrier for many people.

If you've already tried multiple antidepressants without relief, this comparison will clarify whether ketamine might be worth exploring.

What Are SSRIs

SSRIs (selective serotonin reuptake inhibitors) are the most commonly prescribed antidepressants. They include medications like sertraline (Zoloft), escitalopram (Lexapro), and fluoxetine (Prozac). They work by increasing serotonin availability in the brain, though the full therapeutic effect takes weeks to develop.

What Is Ketamine Therapy

Ketamine is an anesthetic medication now used off-label for treatment-resistant depression. Unlike SSRIs, it works through glutamate pathways and produces rapid effects. Therapeutic ketamine is administered as IV infusions, nasal spray (Spravato), or sublingual tablets for at-home use.

What is The Main Difference

SSRIs often take 4-6 weeks to produce therapeutic effects, sometimes longer. The serotonin increase from your first dose happens within hours, but the benefits you'd actually feel require weeks of gradual brain adaptation.

Ketamine works differently. Improvement often begins within hours and is clearly evident by 24 hours. Research published in JAMA Psychiatry (2025) confirms clinically meaningful effects at 24 hours after the first dose.

If you've spent months cycling through SSRI trials that haven't worked, ketamine's rapid onset means you're getting information about whether this approach helps within hours. You're not starting another months-long experiment hoping for different results.

The tradeoff: ketamine's effects from a single treatment typically last about a week, sometimes up to two weeks, so maintaining benefits requires ongoing treatment. SSRIs, once they work, maintain benefits with daily dosing.

Does Ketamine Actually Work Better

If you've tried two or more antidepressants without adequate relief, you meet the clinical definition of treatment-resistant depression (TRD). The medications you've tried haven't worked, and further trials of similar medications tend to have lower chances of success, though some people do respond to later strategies like augmentation or switching classes.

Ketamine offers a completely different mechanism, working through glutamate pathways rather than serotonin. In people whose SSRIs haven't worked, ketamine shows 50-70% response rates. Response means at least 50% reduction in symptoms. Not a cure, but meaningful relief.

To make this concrete: imagine you've tried sertraline for 8 weeks, then escitalopram for another 8 weeks, with minimal improvement. You've spent four months waiting. With ketamine, you'd know within 24-48 hours whether you're responding. If you're among those who do respond, you've potentially saved months of continued suffering.

A note on expectations: recent research in JAMA Psychiatry suggests earlier ketamine studies may have overestimated effects. The real-world benefit, while meaningful, may be more modest than initial headlines suggested. Ketamine helps many people, but results aren't guaranteed. It remains one option among several approaches for TRD, including medication augmentation, TMS, and ECT.

Where Speed Matters Most, Suicidal Thoughts

The difference in timing matters most here.

SSRIs carry a black box warning about increased suicidal thoughts, particularly in young adults during the first weeks of treatment. Even when SSRIs ultimately help, waiting 4-6 weeks can feel impossible when you're in crisis.

Ketamine can reduce suicidal ideation within hours to days. Some research suggests this rapid effect may work partly through different pathways than its antidepressant effects, though this is still being studied. This speed is why ketamine is increasingly considered when waiting weeks isn't safe.

If you're experiencing suicidal thoughts, both ketamine and SSRIs require close clinical supervision. Ketamine's rapid relief doesn't replace safety planning, ongoing support, or access to emergency care, but it can provide breathing room while longer-term treatment takes hold.

What Are the Side Effects and Safety Considerations

SSRI side effects include sexual dysfunction (common and often persistent), nausea, insomnia or drowsiness, weight gain, and withdrawal effects if stopped abruptly. These typically emerge gradually and can persist with ongoing use.

Ketamine side effects happen during and shortly after treatment, then resolve. The most common is dissociation, a feeling of detachment or altered perception, which about 1 in 4 people experience. Others include headache, dizziness, nausea, and temporary blood pressure elevation. These effects are why you're monitored during treatment and can't drive yourself home afterward.

For FDA-approved esketamine (Spravato), this monitoring is formally required for at least 2 hours. At-home ketamine programs use similar protocols adapted for the home setting.

Long-term esketamine data from the SUSTAIN-3 study, extending to 4.5 years, shows no new safety concerns emerging over time.

Ketamine isn't right for everyone. If you have uncontrolled high blood pressure, recent heart attack or stroke, active substance use disorder, or history of psychosis, ketamine likely isn't appropriate. Your clinician will screen for these during evaluation.

What Are the Costs

Cost is often the hardest part of this conversation. In one study, about 64% of people receiving ketamine therapy paid entirely out-of-pocket. That's a significant barrier when you've finally found something that might help.

SSRIs: Often under $10/month with insurance. Widely covered.

FDA-approved esketamine (Spravato): $17,700-25,200 per year. Requires in-clinic administration.

IV ketamine clinics: Often $400-800 per session, typically 6-8 initial sessions plus maintenance. Most don't accept insurance.

At-home sublingual ketamine: $54-125 per session depending on insurance. More accessible for many people.

The gap between what works and what's affordable is a real problem in mental health care. Insurance frameworks built around daily pills haven't caught up to treatments that work differently.

Comparing Key Factors

Who Should Consider Each Option

If you're newly diagnosed with depression or haven't yet tried adequate medication trials, SSRIs remain the reasonable starting point. They're affordable, well-studied, and work for many people. They're also typically preferred if you have heart conditions, active substance use concerns, or history of psychosis. For some people, options like medication augmentation, TMS, or ECT may be more appropriate than ketamine, depending on individual circumstances.

Ketamine makes more sense if you've genuinely tried SSRIs, given adequate time and doses, and they haven't worked. If you need relief faster than weeks allow, can access proper supervision, and can manage the cost and logistics, ketamine offers a meaningfully different approach.

You don't necessarily have to choose one or the other. Many people continue their current antidepressants while adding ketamine. The FDA approved esketamine as adjunct therapy in 2019 and as standalone treatment in 2025, reflecting evidence that both approaches work.

How Innerwell's At-Home Ketamine Therapy Works

If you're considering ketamine, the next question is how to access it. Innerwell offers at-home ketamine therapy that combines medication with licensed therapeutic support.

The medication opens a door; therapy helps you walk through it. Ketamine creates a window of neuroplasticity where your brain is more capable of forming new patterns. What you do during that window, the insights you process, the support you receive, shapes whether changes stick.

The process:

1. Evaluation: A psychiatric clinician reviews your history, confirms you're a good candidate, and screens for safety concerns.
2. Delivery: Sublingual tablets shipped to your door with adult-signature verification.
3. Preparation and integration: Licensed therapists prepare you for sessions and guide integration afterward. This isn't ketamine dropped off with minimal supervision. It's comprehensive care.
4. Ongoing monitoring: Tracking through the Innerwell app, with psychiatric check-ins throughout your program.

Pricing: Foundation Program (8 doses): $599 with insurance ($75/treatment) or $998 self-pay ($125/treatment). Extended Program (24 doses): $1,299 with insurance ($54/treatment) or $1,999 self-pay ($83/treatment).

What improvement looks like: 87% of Innerwell patients report feeling better within 4 weeks. After 10 weeks, the average reduction is 69% for depression symptoms and 60% for anxiety. For context, peer-reviewed studies of at-home sublingual ketamine show 32.6% remission rates. Remission means symptoms drop below clinical thresholds entirely, a higher bar than improvement.

Take the free assessment to see if ketamine therapy might work for you.

Frequently Asked Questions

Do I need to stop my SSRI before starting ketamine?

Usually not. Most people continue their current antidepressants during ketamine treatment. Research supports using ketamine as an addition rather than a replacement. Your clinician will review your medications during evaluation and let you know if anything needs adjustment.

How many ketamine sessions will I need?

Most programs involve 6-8 initial sessions over 2-4 weeks, followed by maintenance every 2-4 weeks. The exact number varies based on how you respond.

Is ketamine better than SSRIs for anxiety?

Most ketamine research focuses on depression. Innerwell's data shows 60% reduction in anxiety symptoms, and many people find their anxiety improves alongside depression. But if anxiety is your primary concern without significant depression, SSRIs have more established evidence for that specific use.

Is ketamine addictive?

Ketamine has abuse potential in recreational settings, but medical programs with proper protocols show low misuse rates. The supervised setting, appropriate dosing, and screening for substance use history distinguish therapeutic use from recreational use.

What if ketamine doesn't work for me?

About 30-50% of people with TRD don't respond adequately to ketamine. That's difficult to hear, but it doesn't mean nothing will help. Options include different protocols, other medications, TMS, or ECT. Finding what works for you may take trying several approaches.